❄
Cryosuite Platform
Cryofixation, cryoimmunostaining, and hybrid microscopy components for consolidated cytology workflows.
Open platform →X-ZELL brings together sample-preserving cytology preparation, multiplex cryoimmunostaining, imaging, verified antibodies, reagents, and OEM supply paths for diagnostic and development partners.
No-obligation enquiry · Typical response within one business day
Regulatory note: X-ZELL's Cryosuite platform, Cryophore™ multiplex panels, and reagents are CE-marked under the EU In Vitro Diagnostic Regulation (IVDR).
Each product family is designed to support a clearer path from limited cytology material to multiplex digital insight.
Cryofixation, cryoimmunostaining, and hybrid microscopy components for consolidated cytology workflows.
Open platform →Preconfigured multiplex panel concepts for cytology contexts such as pleural and ascitic fluids, with market-specific status documentation on request.
View panels →Multiplex-ready antibodies and conjugation support for assay developers and cytology workflow teams.
View antibodies →Fixation, staining, buffer, and workflow reagents supported by traceability and documentation pathways.
View reagents →Private-label and contract reagent manufacturing for distributors, IVD developers, and regional partners.
Explore OEM →A guided request path for product documentation, analytical verification summaries, and regulatory status clarification.
Request evidence →The platform is organized around five practical stages so labs can evaluate fit, training needs, documentation, and implementation requirements.
Limited cytology material is handled with attention to cell preservation and downstream multiplexing requirements.
Direct-to-slide preparation helps reduce reliance on serial cell-block workflows where appropriate.
Cryophore panel and antibody configurations support multi-channel marker review.
Hybrid microscopy captures channels for digital review and documentation.
Pathology teams review multiplex marker context with the relevant validation and intended-use documentation.
Different partners need different evidence, support, and commercial information.
Evaluate workflow fit, sample handling, documentation, and training needs.
Start with workflow →Review platform scalability, evidence summaries, and documentation request paths.
Review evidence →Explore regional product availability, tender support, training, and partner models.
Partner pathways →Discuss private-label reagents, conjugation, lot traceability, and quality documentation.
OEM options →Tell us your organisation type, country, and area of interest so X-ZELL can route your enquiry correctly.